Literature DB >> 5891709

Defibrination syndrome with defective thrombinfibrinogen reaction reversible by protamine.

A L Bloom, N Campbell.   

Abstract

A patient with the obstetric defibrination syndrome successfully treated with human fibrinogen is described. The blood not only contained low levels of fibrinogen capable of clotting but also contained an inhibitor of the thrombin-fibrinogen reaction. This was neutralized in vitro with protamine but it was not heparin. Neither abnormality was detected by a latex agglutination test for plasma fibrinogen. The use of this test does not therefore exclude the diagnosis of the defibrination syndrome.

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5891709      PMCID: PMC473135          DOI: 10.1136/jcp.18.6.786

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  An immunological method for demonstrating fibrin degradation products in serum and its use in the diagnosis of fibrinolytic states.

Authors:  H C FERREIRA; L G MURAT
Journal:  Br J Haematol       Date:  1963-07       Impact factor: 6.998

2.  Problems in hemostasis during and after open-heart surgery. VI. Over-all changes in blood coagulation mechanism.

Authors:  H GANS; W KRIVIT
Journal:  JAMA       Date:  1962-01-13       Impact factor: 56.272

3.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

4.  Coexistent hypercoagulability and acute hypofibrinogenemia in a patient with prostatic carcinoma.

Authors:  S I RAPAPORT; C G CHAPMAN
Journal:  Am J Med       Date:  1959-07       Impact factor: 4.965

5.  Defibrination syndrome in pregnancy: value of various diagnostic tests.

Authors:  A A SHARP; B HOWIE; R BIGGS; D T METHUEN
Journal:  Lancet       Date:  1958-12-20       Impact factor: 79.321

6.  Clotting deviations in man during cardiac bypass: fibrinolysis and circulating anticoagulant.

Authors:  K N VON KAULLA; H SWAN
Journal:  J Thorac Surg       Date:  1958-10

7.  A rapid screening test for disorders of thromboplastin generation.

Authors:  N D HICKS; W R PITNEY
Journal:  Br J Haematol       Date:  1957-04       Impact factor: 6.998

8.  The effect of intravenous infusion of thromboplastin on "heparin tolerance".

Authors:  R C HARTMANN; C L CONLEY; J R KREVANS
Journal:  J Clin Invest       Date:  1951-09       Impact factor: 14.808

9.  Studies on afibrinogenemia. II. The defibrinating effect on dog blood of intravenous injection of thromboplastic material.

Authors:  O D RATNOFF; C L CONLEY
Journal:  Bull Johns Hopkins Hosp       Date:  1951-05

10.  A haemorrhagic disorder in pregnancy due to an "anticoagulant" preventing the conversion of fibrinogen to fibrin.

Authors:  S J BAKER; E JACOB
Journal:  J Clin Pathol       Date:  1960-05       Impact factor: 3.411

View more
  3 in total

1.  Detection of fibrinogen-fibrin degradation products by counterelectrophoresis.

Authors:  J I Brody
Journal:  J Clin Pathol       Date:  1972-09       Impact factor: 3.411

2.  A study of two methods for estimating plasma fibrinogen and the effect of epsilon aminocaproic acid and protamine.

Authors:  J C Giddings; A L Bloom
Journal:  J Clin Pathol       Date:  1971-07       Impact factor: 3.411

3.  Coagulation studies in massive pulmonary haemorrhage of the newborn.

Authors:  J T Roberts; A J Davies; A L Bloom
Journal:  J Clin Pathol       Date:  1966-07       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.